12:00 AM
 | 
Mar 29, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Apligraf: Marketed to treat venous ulcers of >1 month duration that have resisted healing with traditional treatment

Data from the 136 patients who were randomized to compression therapy in Apligraf's pivotal trial showed that patients who did not heal with compression therapy demonstrated...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >